Your browser doesn't support javascript.
loading
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemia.
Kim, Dennis D H; Novitzky Basso, Igor; Kim, Taehyung Simon; Yi, Seong Yoon; Kim, Kyoung Ha; Murphy, Tracy; Chan, Steven; Minden, Mark; Pasic, Ivan; Lam, Wilson; Law, Arjun; Michelis, Fotios V; Gerbitz, Armin; Viswabandya, Auro; Lipton, Jeffrey; Kumar, Rajat; Ng, Stanley W K; Stockley, Tracy; Zhang, Tong; King, Ian; Mattsson, Jonas; Wang, Jean C Y.
Afiliação
  • Kim DDH; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Novitzky Basso I; Faculty of Medicine University of Toronto Toronto Canada.
  • Kim TS; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Yi SY; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Kim KH; Department of Computer Science University of Toronto Toronto Canada.
  • Murphy T; The Donnelly Centre for Cellular and Biomolecular Research University of Toronto Toronto Canada.
  • Chan S; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Minden M; Department of Internal Medicine Inje University Ilsan Paik Hospital Goyang Korea.
  • Pasic I; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Lam W; Department of Internal Medicine College of Medicine Seoul Hospital Soonchunhyang University Seoul Korea.
  • Law A; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Michelis FV; Faculty of Medicine University of Toronto Toronto Canada.
  • Gerbitz A; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Viswabandya A; Faculty of Medicine University of Toronto Toronto Canada.
  • Lipton J; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Kumar R; Faculty of Medicine University of Toronto Toronto Canada.
  • Ng SWK; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Stockley T; Faculty of Medicine University of Toronto Toronto Canada.
  • Zhang T; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • King I; Faculty of Medicine University of Toronto Toronto Canada.
  • Mattsson J; Department of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
  • Wang JCY; Faculty of Medicine University of Toronto Toronto Canada.
EJHaem ; 3(3): 873-884, 2022 Aug.
Article em En | MEDLINE | ID: mdl-36051057
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: EJHaem Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: EJHaem Ano de publicação: 2022 Tipo de documento: Article